Latest Kaiser Health News Stories
Treatment has been terminated for some seniors because therapists told them they weren’t making enough progress or that they had reached their annual limit. We examine the treatment benefits and the barriers under Medicare’s coverage rules for therapy.
Standards for how to investigate and report on overdoses vary widely across states and counties. As a result, opioid overdose deaths often go overlooked in the data reported to the federal government.
California health officials do not dispute most of the findings, saying they have already made improvements in determining eligibility.
Opioid overdoses and related deaths are still climbing, U.S. statistics show. Teasing out which overdoses are intentional can be hard, but is important for treatment, doctors say.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
In some cases, information now available to people without talking to a doctor can be a source of confusion and alarm and the cause of more work for doctors because it comes without adequate guidance.
In a program called OB Nest, Mayo has been using a telemedicine program in its obstetrics clinic in Rochester, Minn., that allows low-risk expectant mothers to forego some standard prenatal visits.
Research out Monday offers evidence that advertising for e-cigarettes and other new tobacco products, which aren’t subject to the same restrictions that apply to the marketing traditional cigarettes, is stoking use among adolescents and young-adult smokers.
Families and nursing homes say Trump administration policies threaten to drive immigrants away from caring for older and disabled patients, intensifying a shortage in these low-wage jobs.
The teenage smoking sensation appearing on high school campuses across the country is an easy-to-hide, high-nicotine device called the Juul. Educators and health care advocates fear that vulnerable young people may become addicted.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Margot Sanger-Katz of The New York Times discuss the apparent demise of bipartisan legislation aimed at shoring up parts of the Affordable Care Act. They also discuss aggressive new efforts by the Food and Drug Administration to regulate tobacco products. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.
In September, the Trump administration announced its plan to end the Deferred Action for Childhood Arrivals program, setting off an ongoing political and legal battle that could doom the dreams of immigrant doctors in training.
Almost three-quarters of Americans think the pharmaceutical industry has too much power in the nation’s capital, according to the Kaiser Family Foundation.
The deadly storm turned a health challenge into a full-blown medical crisis for one young man with unconfirmed multiple sclerosis. And still he waits to see a neurologist.
Medicaid family planning programs reduce unplanned births, but some are caught in disputes over federal funding to Planned Parenthood.
Though opioid prescriptions appear to be on the decline, Vicodin and Norco remain popular, especially in the South. In more than half of states, Synthroid — a drug to treat hypothyroidism — came in at No. 1.
Critics say the Trump administration failed to properly vet Dr. Robert Redfield as they attribute a pattern of “ethically and morally questionable behavior” to him.
Health care tech startup Theranos was riding high back in 2014. But when a reporter raised questions, its media reps circled the wagons.
As Congress considers a bipartisan bill to help hold down premium prices on the health law’s marketplaces, a long-standing fight over abortion reappears.
Scientists are finding that, just as with secondhand smoke from tobacco, inhaling secondhand smoke from marijuana can make it harder for arteries to expand to allow a healthy flow of blood.